Skip to main content
. 2024 Dec 5;44(6):408-413. doi: 10.5144/0256-4947.2024.408

Table 3.

Comparison between our FETO patients and FETO group of latest trial.

Current series (n=5) Treatment arm (TOTAL trial), (n=40)
Gestationl age at balloon insertion (weeks) 29 (27–29) 28.6 (28–29)
Mothers age at FETO (median, years) 28 32
Survival to discharge 40% 40%
Liver herniation (%) 100% 90%
Observed/expected lung-to-head ratio % 23 21
Duration of occlusion (days) 30 34

Gestational age is median (IQR).